TIGER Köln-3903 (#1229)
Laufzeit: 01.01.2021 - 31.12.2023
imported
Kurzfassung
Phase II trial of TisaGenlecleucel in Elderly Patients with First-Relapsed or Primary Refractory Agressive B-cell Non-Hodgkin Lymphoma (TIGER_CTL019)
